vitiligo
Conditions
Interventions
Experimental group:Dermaroller+NB-UVB+0.03% tacrolimus ointment
Control group:NB-UVB+0.03% tacrolimus ointment
Sponsors
People's Hospital of Shapingba District, Chongqing
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Vitiligo was diagnosed according to the definition and clinical characteristics of Dermatology 2nd Edition, which was in accordance with any classification determined by the 2012 Global Consensus Conference on Vitiligo and the expert discussion; (2) Non-Segmental vitiligo with symmetrical skin lesions (hands, feet, arms, legs, armpits, elbows, knees, etc.); (3) Skin lesions stabilize at least 1 month (some literatures are stable patients).
Exclusion criteria
Exclusion criteria: (1) Chronic diseases such as anemia, nephropathy, liver disease, diabetes mellitus, ischemic heart disease, tumors, central nervous system diseases, alcoholism, drug dependence, other chronic diseases with concomitant medications (such as statins, antihypertensive drugs, minocycline, aspirin, glucocorticoid, etc.) and immunosuppressive status; (2) Combined with other skin diseases; (3) Having coagulation dysfunction or hemorrhagic diseases or using anticoagulants; (4) Scar constitution; (5) Pregnant women and lactating women; (6) Active labial herpes; (7) Infection of white spot; (8) Been treated within past one month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the area of vitiligo; | — |
Countries
China
Contacts
Public ContactZheng Chen
The People’s Hospital of Shapingba District
Outcome results
None listed